Recombinant Pseudomonas aeruginosa flagellin delivered using ferritin nanoparticles provides enhanced cross-protection against lung infection in mice
Molecular Immunology · 2023
DOI: 10.1016/j.molimm.2023.10.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Immunology, 2023. Verfasst von Yujie Wei und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioengineering, Chongqing University, Chongqing 400044, China; National Engineering Research Center of Immunological Products, Department …. Hauptthemen laut MEDLINE: Nanoparticles, Vaccines, Pseudomonas Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, National Key Research and Development Program of China Stem Cell and Translational Research.
Abstract (Originalsprache)
Increasing prevalence of multidrug- and pan-drug-resistant Pseudomonas aeruginosa (PA) strains has created an urgent need for an effective vaccine. Flagellin is an essential vaccine target because of its contribution to bacterial motility and other pathogenic processes. However, flagellin-based vaccines have not been successful thus far, probably due to a lack of efficient adjuvants or delivery systems. In this study, we genetically fused an A-type flagellin (FliC) to the self-assembled nanocarrier ferritin to construct the nanoparticle vaccine, reFliC-ferritin (reFliC-FN). reFliC-FN formed homogenous nanoparticles and induced a quick T helper 1 (Th1)-predominant immune response, which was quite different from that induced by recombinant FliC alone. In addition, reFliC-FN provided enhanced protection against PA strains carrying the A-type and heterogeneous B-type flagellins. Preliminary safety assays revealed the good biocompatibility and biosafety of reFliC-FN. Therefore, our data highlight the potential of ferritin as an ideal delivery system and suggest reFliC-FN as a promising PA vaccine candidate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Bioengineering, Chongqing University, Chongqing 400044, China; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third M…
- National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, China.
- National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, China. Electronic address: j…
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- National Key Research and Development Program of China Stem Cell and Translational Research
Zitieren
APA
Wei, Y., Cheng, X., Liao, Y., Zeng, S., Li, Y., Zhang, Y., Gao, C., Zhang, Y., Wan, J., Gu, J., & Zou, Q. (2023). Recombinant Pseudomonas aeruginosa flagellin delivered using ferritin nanoparticles provides enhanced cross-protection against lung infection in mice. Molecular Immunology. https://doi.org/10.1016/j.molimm.2023.10.005
Vancouver
Wei Y, Cheng X, Liao Y, Zeng S, Li Y, Zhang Y, et al. Recombinant Pseudomonas aeruginosa flagellin delivered using ferritin nanoparticles provides enhanced cross-protection against lung infection in mice. Molecular Immunology. 2023. doi:10.1016/j.molimm.2023.10.005
BibTeX
@article{Wei2023,
author = {Wei, Yujie and Cheng, Xin and Liao, Yaling and Zeng, Sheng and Li, Yuhang and Zhang, Yiwen and Gao, Chen and Zhang, Yi and Wan, Jiqing and Gu, Jiang and Zou, Quanming},
title = {Recombinant Pseudomonas aeruginosa flagellin delivered using ferritin nanoparticles provides enhanced cross-protection against lung infection in mice},
journal = {Molecular Immunology},
year = {2023},
doi = {10.1016/j.molimm.2023.10.005}
}
EUVIMED